However, other PDGFRB fusion partners including WDR48, PDE4DIP, RAB5EP, PRKG2, SPTBN1, BIN2, TP53BP1, NUMA1, TSC1, and CEV14 have also been reported in myeloid neoplasms (Gong et al., 2016; Jawhar et al., 2017; Zhang et al., 2018; Zou et al., 2017). This evidence concerns the gene PDGFRB and myeloid neoplasm.